JACOBS LEVY EQUITY MANAGEMENT, INC
Position in GOSS — Gossamer Bio, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in GOSS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$360,921
-$196,786 QoQ
Shares Held
2,187,402
+29.0% QoQ
Ownership
0.447%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 168 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. GOSS ranks #71 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in GOSS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $360,921 | 2,187,402 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $557,707 | 1,695,159 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,751,902 | 2,178,033 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,703,350 | 1,408,118 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,342,623 | 1,091,564 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $310,490 | 282,264 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,388,874 | 1,534,668 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,861,086 | 1,887,512 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,301,599 | 1,444,617 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,928,219 | 1,634,084 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,920,082 | 2,103,048 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $5,316,465 | 612,496 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,274,365 | 908,432 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,285,452 | 977,363 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,172,609 | 1,006,479 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,810,124 | 1,060,554 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,104,496 | 631,282 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,021,985 | 646,413 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,416,114 | 262,778 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $941,239 | 92,733 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||